Kapil Bahl

4.3k total citations · 1 hit paper
22 papers, 1.6k citations indexed

About

Kapil Bahl is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Kapil Bahl has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Kapil Bahl's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Kapil Bahl is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Kapil Bahl collaborates with scholars based in United States, United Kingdom and Sweden. Kapil Bahl's co-authors include Raymond M. Welsh, Kimberly J. Hassett, Giuseppe Ciaramella, Olga Yuzhakov, Luis A. Brito, Heather D. Marshall, Stina L. Urban, Tal Zaks, James D. Thompson and Mike Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Kapil Bahl

22 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

2017 493 citations Kapil Bahl, Olga Yuzhakov et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kapil Bahl United States	17	767	730	652	292	200	22	1.6k
Annette B. Vogel Germany	14	884 1.2×	500 0.7×	724 1.1×	292 1.0×	244 1.2×	19	1.6k
Kimberly J. Hassett United States	12	1.5k 1.9×	742 1.0×	827 1.3×	306 1.0×	247 1.2×	14	2.2k
Olga Yuzhakov United States	9	1.2k 1.6×	563 0.8×	794 1.2×	310 1.1×	220 1.1×	10	1.8k
Patrick Baumhof Germany	11	976 1.3×	479 0.7×	447 0.7×	145 0.5×	226 1.1×	14	1.3k
Sunny Himansu United States	11	1.1k 1.4×	397 0.5×	924 1.4×	281 1.0×	198 1.0×	15	1.9k
Frédéric Martinon France	21	684 0.9×	986 1.4×	449 0.7×	324 1.1×	145 0.7×	54	1.8k
Frank Liang Sweden	17	502 0.7×	850 1.2×	317 0.5×	220 0.8×	135 0.7×	26	1.4k
Jasdave S. Chahal United States	10	970 1.3×	581 0.8×	320 0.5×	140 0.5×	232 1.2×	12	1.4k
Pavlo Gilchuk United States	21	631 0.8×	807 1.1×	1.4k 2.1×	670 2.3×	84 0.4×	49	2.4k
Christine A. Shaw United States	16	674 0.9×	342 0.5×	652 1.0×	630 2.2×	175 0.9×	33	1.5k

Countries citing papers authored by Kapil Bahl

Since Specialization

Citations

This map shows the geographic impact of Kapil Bahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kapil Bahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kapil Bahl more than expected).

Fields of papers citing papers by Kapil Bahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kapil Bahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kapil Bahl. The network helps show where Kapil Bahl may publish in the future.

Co-authorship network of co-authors of Kapil Bahl

This figure shows the co-authorship network connecting the top 25 collaborators of Kapil Bahl. A scholar is included among the top collaborators of Kapil Bahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kapil Bahl. Kapil Bahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer, Michelle, Chiaowen Joyce Hsiao, Albert B. Jeon, et al.. (2023). Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Science Advances. 9(38). eadh1655–eadh1655. 43 indexed citations

Hassett, Kimberly J., et al.. (2023). mRNA vaccine trafficking and resulting protein expression after intramuscular administration. Molecular Therapy — Nucleic Acids. 35(1). 102083–102083. 51 indexed citations

Nunna, Naveen, Kapil Bahl, Chiaowen Joyce Hsiao, et al.. (2023). An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. npj Vaccines. 8(1). 58–58. 44 indexed citations

Flynn, Jessica A., Teresa M. Weber, Pedro J. Cejas, et al.. (2022). Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates. Vaccine. 40(32). 4412–4423. 8 indexed citations

Henry, Carole, LingZhi Ma, Nicholas J. Amato, et al.. (2022). Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice. Frontiers in Immunology. 13. 948335–948335. 7 indexed citations

Moyo, Nathifa, Edmund G. Wee, Bette Korber, et al.. (2020). Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth. Vaccines. 8(3). 360–360. 18 indexed citations

Roth, Claude, Tineke Cantaert, Matthieu Prot, et al.. (2019). A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice. Frontiers in Immunology. 10. 1424–1424. 69 indexed citations

Bahl, Kapil, Olga Yuzhakov, Alex Bulychev, et al.. (2017). Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Molecular Therapy. 25(6). 1316–1327. 493 indexed citations breakdown →

Lindgren, Gustaf, Sebastian Ols, Frank Liang, et al.. (2017). Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells. Frontiers in Immunology. 8. 1539–1539. 102 indexed citations

10.

Liang, Frank, Gustaf Lindgren, Ang Lin, et al.. (2017). Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques. Molecular Therapy. 25(12). 2635–2647. 274 indexed citations

11.

Schell, John B., Kapil Bahl, Ewa Folta‐Stogniew, et al.. (2015). Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus. Virology. 476. 405–412. 10 indexed citations

12.

Rose, Nina F., Linda Buonocore, John B. Schell, et al.. (2014). In vitro evolution of high-titer, virus-like vesicles containing a single structural protein. Proceedings of the National Academy of Sciences. 111(47). 16866–16871. 30 indexed citations

13.

Welsh, Raymond M., Kapil Bahl, Heather D. Marshall, & Stina L. Urban. (2012). Type 1 Interferons and Antiviral CD8 T-Cell Responses. PLoS Pathogens. 8(1). e1002352–e1002352. 143 indexed citations

14.

Schell, John B., Kapil Bahl, Nina F. Rose, et al.. (2012). Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: Protection correlates with neutralizing antibody. Vaccine. 30(28). 4233–4239. 8 indexed citations

15.

Bahl, Kapil, Anette Hübner, Roger J. Davis, & Raymond M. Welsh. (2010). Analysis of Apoptosis of Memory T Cells and Dendritic Cells during the Early Stages of Viral Infection or Exposure to Toll-Like Receptor Agonists. Journal of Virology. 84(12). 6262–6262. 2 indexed citations

16.

Thornley, Thomas B., Nancy E. Phillips, Britte Beaudette-Zlatanova, et al.. (2007). Type 1 IFN Mediates Cross-Talk between Innate and Adaptive Immunity That Abrogates Transplantation Tolerance. The Journal of Immunology. 179(10). 6620–6629. 59 indexed citations

17.

Peacock, Craig D., et al.. (2007). Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation. The Journal of Experimental Medicine. 204(10). 2321–2333. 53 indexed citations

18.

Bahl, Kapil, Claudia Calcagno, Dario Ghersi, et al.. (2006). IFN-Induced Attrition of CD8 T Cells in the Presence or Absence of Cognate Antigen during the Early Stages of Viral Infections. The Journal of Immunology. 176(7). 4284–4295. 95 indexed citations

19.

Welsh, Raymond M., et al.. (2004). Apoptosis and loss of virus-specific CD8+ T-cell memory. Current Opinion in Immunology. 16(3). 271–276. 23 indexed citations

20.

Schünemann, Volker, Alfred X. Trautwein, Ivonne M.C.M. Rietjens, et al.. (1999). Characterization of Iron(III) Tetramesitylporphyrin and Microperoxidase-8 Incorporated into the Molecular Sieve MCM-41. Inorganic Chemistry. 38(21). 4901–4905. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact